Mental-health before and during the COVID-19 pandemic in adults with neurodevelopmental disorders.


Journal

Journal of psychiatric research
ISSN: 1879-1379
Titre abrégé: J Psychiatr Res
Pays: England
ID NLM: 0376331

Informations de publication

Date de publication:
03 2023
Historique:
received: 17 05 2022
revised: 11 01 2023
accepted: 26 01 2023
pubmed: 9 2 2023
medline: 25 2 2023
entrez: 8 2 2023
Statut: ppublish

Résumé

The COVID-19 pandemic negatively impacted mental health globally. Individuals with neurodevelopmental disorders (NDDs), including autism spectrum disorder (ASD) and attention deficit hyperactivity disorder (ADHD), are at elevated risk of mental health difficulties. We investigated the impact of the pandemic on anxiety, depression and mental wellbeing in adults with NDDs using data from the Avon Longitudinal Study of Parents and Children (n = 3058). Mental health data were collected pre-pandemic (age 21-25) and at three timepoints during the pandemic (ages 27-28) using the Short Mood and Feelings Questionnaire, Generalized Anxiety Disorder Assessment-7, and Warwick Edinburgh Mental Wellbeing Scale. ADHD and ASD were defined using validated cut-points of the Strengths and Difficulties Questionnaire and Autism Spectrum Quotient, self-reported at age 25. We used multi-level mixed-effects models to investigate changes in mental health in those with elevated ADHD/ASD traits compared to those without. Prevalences of depression, anxiety and poor mental wellbeing were higher at all timepoints (pre-pandemic and during pandemic) in those with ADHD and ASD compared to those without. Anxiety increased to a greater extent in those with ADHD (β = 0.8 [0.2,1.4], p = 0.01) and ASD (β = 1.2 [-0.1,2.5], p = 0.07), while depression symptoms decreased, particularly in females with ASD (β = -3.1 [-4.6,-1.5], p = 0.0001). On average, mental wellbeing decreased in all, but to a lesser extent in those with ADHD (β = 1.3 [0.2,2.5], p = 0.03) and females with ASD (β = 3.0 [0.2,5.9], p = 0.04). To conclude, anxiety disproportionately increased in adults with NDDs during the pandemic, however, the related lockdowns may have provided a protective environment for depressive symptoms in the same individuals.

Identifiants

pubmed: 36753897
pii: S0022-3956(23)00036-5
doi: 10.1016/j.jpsychires.2023.01.029
pmc: PMC9885110
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

230-239

Subventions

Organisme : Medical Research Council
ID : MC_PC_19009
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 204895/Z/16/Z
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00011/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_15018
Pays : United Kingdom
Organisme : Medical Research Council
ID : G9815508
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00011/3
Pays : United Kingdom
Organisme : wel
ID : 217065/Z/19/Z

Informations de copyright

Copyright © 2023 The Authors. Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors report no conflicting interests.

Références

Mol Autism. 2021 Mar 3;12(1):21
pubmed: 33658046
Autism. 2022 May;26(4):914-927
pubmed: 34362263
Lancet Psychiatry. 2020 Jun;7(6):547-560
pubmed: 32304649
Psychol Med. 2016 Jan;46(1):73-85
pubmed: 26315278
Int J Epidemiol. 2013 Feb;42(1):97-110
pubmed: 22507742
BMJ. 2020 Apr 27;369:m1557
pubmed: 32341002
PLoS One. 2020 Mar 25;15(3):e0230623
pubmed: 32210463
Paediatr Child Health. 2021 May 27;26(5):e199-e207
pubmed: 34326910
J Child Psychol Psychiatry. 2012 Jan;53(1):73-80
pubmed: 21923806
Arch Intern Med. 2006 May 22;166(10):1092-7
pubmed: 16717171
Autism Res. 2019 Oct;12(10):1516-1528
pubmed: 31274233
JAMA. 2020 Dec 22;324(24):2555-2557
pubmed: 33226420
Autism. 2022 Oct;26(7):1765-1782
pubmed: 35083922
Front Psychiatry. 2021 Oct 20;12:746276
pubmed: 34744839
Autism. 2021 Jan;25(1):70-78
pubmed: 32772703
Lancet Child Adolesc Health. 2021 Aug;5(8):535-537
pubmed: 34174991
Autism. 2022 May;26(4):975-987
pubmed: 34420427
Br J Psychiatry. 2021 Jun;218(6):334-343
pubmed: 33228822
BJPsych Open. 2022 Mar 07;8(2):e59
pubmed: 35249586
Gen Psychiatr. 2021 Feb 9;34(1):e100424
pubmed: 33644689
Neurosci Biobehav Rev. 2021 Sep;128:789-818
pubmed: 33549739
Lancet Psychiatry. 2019 Nov;6(11):903-914
pubmed: 31543474
Lancet Psychiatry. 2021 Jul;8(7):610-619
pubmed: 33965057
Autism Res. 2014 Jun;7(3):344-54
pubmed: 24610869
Int J Epidemiol. 2013 Feb;42(1):111-27
pubmed: 22507743
J Epidemiol Community Health. 2021 Mar;75(3):224-231
pubmed: 32978210
Autism Res. 2021 Oct;14(10):2113-2119
pubmed: 34231323
Psychiatry Res. 2017 Jul;253:84-90
pubmed: 28359032
Cancer Chemother Rep. 1966 Mar;50(3):163-70
pubmed: 5910392
World Psychiatry. 2021 Feb;20(1):124-130
pubmed: 33026219
Autism Res. 2022 Jan;15(1):93-102
pubmed: 34626164
Lancet. 2021 Nov 6;398(10312):1700-1712
pubmed: 34634250
Lancet. 2016 Mar 19;387(10024):1240-50
pubmed: 26386541
J Child Psychol Psychiatry. 2022 Nov;63(11):1332-1343
pubmed: 35194802
Psychol Med. 2021 Aug;51(11):1890-1897
pubmed: 32249726
J Child Psychol Psychiatry. 1997 Jul;38(5):581-6
pubmed: 9255702
PLoS Pathog. 2021 Jun 24;17(6):e1009620
pubmed: 34166465
Autism. 2020 Apr;24(3):680-692
pubmed: 31709804
Autism. 2021 Oct;25(7):2140-2145
pubmed: 33845620
J Affect Disord. 2022 Jan 1;296:567-576
pubmed: 34600966
J Atten Disord. 2021 Nov;25(13):1783-1790
pubmed: 32697120
J Affect Disord. 2021 Nov 1;294:883-888
pubmed: 34375216
Health Qual Life Outcomes. 2007 Nov 27;5:63
pubmed: 18042300
Lancet Reg Health Eur. 2021 Dec;11:100228
pubmed: 34877563
Wellcome Open Res. 2019 Mar 14;4:51
pubmed: 31020050
Autism Res. 2021 Jun;14(6):1209-1219
pubmed: 33559334
J Anxiety Disord. 2014 Jun;28(5):437-45
pubmed: 24858656
Autism Res. 2018 Jan;11(1):142-152
pubmed: 29266823
J Eat Disord. 2021 Dec 3;9(1):155
pubmed: 34861897
J Atten Disord. 2022 Feb;26(4):491-501
pubmed: 33797281
J Autism Dev Disord. 2017 Aug;47(8):2519-2534
pubmed: 28527095
Int J Environ Res Public Health. 2021 Feb 21;18(4):
pubmed: 33669970
Mol Autism. 2021 Feb 16;12(1):13
pubmed: 33593423
J Autism Dev Disord. 2001 Feb;31(1):5-17
pubmed: 11439754
J Autism Dev Disord. 2019 Mar;49(3):819-833
pubmed: 30361940
Int J Epidemiol. 2018 Aug 1;47(4):1207-1216
pubmed: 29800128
JAMA Netw Open. 2022 Apr 1;5(4):e227629
pubmed: 35452109
JAMA. 2020 Jul 7;324(1):93-94
pubmed: 32492088
Autism Res. 2021 Dec;14(12):2663-2676
pubmed: 34545706
Encephale. 2020 Jun;46(3S):S85-S92
pubmed: 32522407
Autism. 2020 Feb;24(2):352-363
pubmed: 31319684
BMJ Open. 2021 Jan 11;11(1):e044640
pubmed: 33431495
Psychiatry Res. 2021 Jul;301:113984
pubmed: 33991992
PeerJ. 2013 Jul 09;1:e98
pubmed: 23862109

Auteurs

Amy Shakeshaft (A)

Division of Psychological Medicine and Clinical Neurosciences, Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, UK; Wolfson Centre for Young People's Mental Health, Cardiff University, UK.

Rachel Blakey (R)

Population Health Sciences and MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK.

Alex S F Kwong (ASF)

Population Health Sciences and MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK; Division of Psychiatry, University of Edinburgh, UK.

Lucy Riglin (L)

Division of Psychological Medicine and Clinical Neurosciences, Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, UK; Wolfson Centre for Young People's Mental Health, Cardiff University, UK.

George Davey Smith (G)

Population Health Sciences and MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK.

Evie Stergiakouli (E)

Population Health Sciences and MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK.

Kate Tilling (K)

Population Health Sciences and MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK.

Anita Thapar (A)

Division of Psychological Medicine and Clinical Neurosciences, Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, UK; Wolfson Centre for Young People's Mental Health, Cardiff University, UK. Electronic address: Thapar@cardiff.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH